About Cordlife
About Cordlife

Corporate Profile

Cordlife Group Limited at a glance

Cordlife Group Limited ("Cordlife", together with its subsidiaries, the "Group") is a consumer healthcare company catering to the mother and child segment. Established in May 2001 and successfully listed on the Mainboard of Singapore Exchange Trading Limited ("SGX-ST") in 2012, the Group is one of the pioneers in the cord blood banking industry in Asia.

Cordlife is amongst the leading players for private cord blood banking services in all the markets it operates in, namely Singapore, Hong Kong, Malaysia, India, Indonesia and the Philippines. Inhabiting a distinctive niche in the healthcare industry, the Group is one of the foremost private cord blood banks to have gained a solid foothold in Asia. In the last 17 years, Cordlife has dedicated its undertakings to achieve market leadership in the industry. Having built a distinguished brand name, the Group continues to strive for excellence by means of support from its experienced management team, dynamic key executives along with its quality product and service offerings. Cordlife believes the Group has in place a strong foundation for future expansion.

In addition to cord blood, cord lining, and cord tissue banking, Cordlife offers families a comprehensive suite of diagnostics services, such as non-invasive prenatal testing, paediatric vision screening, and newborn metabolic screening. At Cordlife, our primary commitment revolves around two key areas: ensuring reliable quality and placing you, our valued customer, at the centre of everything we do. Our mission is to make transfusion medicine and biotherapies safe, available, and effective on a global scale. We strive to maintain the highest standards in cord blood banking for your confidence and well-being.

In the area of clinical diagnostics, Cordlife India and Healthbaby Hong Kong are both accredited by the College of American Pathologists (“CAP”). This makes Healthbaby Hong Kong the only private cord blood bank in the world to be accredited by three international standard-setting bodies, and Cordlife India is one of the only two medical laboratories in West Bengal to be holding accreditations from the National Accreditation Board for Testing and Calibration Laboratories (“NABL”) and CAP. These quality achievements reinforce the Group’s commitment to providing reliable healthcare solutions through innovation and technological advancement.

About Cordlife India

Cordlife India is a fully owned subsidiary of Cordlife Group Limited. The Indian Laboratory is AABB accredited and operates the most advanced umbilical cord and cord blood processing, testing and cryopreservation facility in the country, with a storage capacity of 150,000 cord blood units scalable by another few lakh units.

The state-of-the-art laboratory is equipped with the latest and the most modern equipment and has recently upgraded from the automated Sepax®2 to the FDA approved AXP®II. Its MNC (Mono Nuclear Cells) and CD34+ recovery rate is higher.[1]

It maintains a clean-room infrastructure to ensure that stem cells are processed under the most sterile conditions. Located within a natural calamity proof building, the facility is also built with continuous power backup and round-the-clock surveillance system. Cordlife operates in more than 210 cities across India, making it one of the largest stem cell banking companies locally.

1. Christy Kim et al. Meta-analysis of the AXP® and SEPAX® automated cord blood processing systems. CESCA Therapeutics White Paper; 2015.

About Corcell Bangladesh

Cordcell Bangladesh will mainly focus upon creating market awareness among all the expectant parents and their close relatives or friends. The business of Cordcell will be managed by a team of medical doctors, qualified pharmacist, bio technologist and genetic engineers. Their endeavour is to deliver international quality of healthcare services through its existing market of private hospitals, obstetricians and gynaecologists in Bangladesh. They will offer the service to collect cord blood and cord cell sample from Bangladesh and will ensure timely transportation of sample to Cordlife India for preservation. Cordcell Bangladesh will be local point of contact in Bangladesh for Cordlife Sciences India Pvt Ltd.